Skip to content

Dr André HURLET

Active Private limited companyfounded 2007active for 19 yearsRue du Vieux Bois 11, 4130 EsneuxKBO/BCE: BE 0890.458.218

Lifetime

18 annual accounts with figures on one time axis
Gross marginpeak €94,640 (2011)
€59,821▲ 44.6%
Resultlowest -€4,972 (2018)
€36,734▲ 43.0%
Equitypeak €209,941 (2025)
€209,941▲ 10.2%
Debts
€26,098▲ 396%
Board1 name since 2022
1 directorAndré HURLET
Documentsfilings and deeds
30-01-20261 days before the deadline
2025micro format
Gross margin from €41,357 to €59,821Result from €25,683 to €36,734Dividend €17,285Debts from €5,261 to €26,098Investments €43,706

Key points

from the 2025 annual accounts

Equity

€209,941 ▲ 10.2%
190,4912024+36,734Profit-17,285Dividend209,9412025

Dr André HURLET paid out €17,285 in dividends. That is 47% of the 2025 profit.

Investments

€43,706 6.4 × depreciation

Green is investment, beige is depreciation.

Liquidity

7.81 was 40.00 in 2024

Short-term debts rose from €4,894 to €25,500.

Checked score

97
Excellent
Financially stronger than 78% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.2%▲ +0.1 percentage points vs 01-2025highest value 03-2025: 0.1%▼ -0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026

Financial strength
Strong

Solvency
100=equity 88.9% of total assets
Liquidity
99-1short-term debt 10.8% · cash 43.6%
Profitability
88+3return on assets 15.6%

Score breakdown

raises risk
No main activity registered
lowers risk
Size: total assets €236,039
Liquidity: current ratio 7.81, cash €102,969
Equity €209,941 (88.9% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 90% on liquidity, 71% on profitability and 68% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-06-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 34,693 companies had the same profile as Dr André HURLET has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of Dr André HURLET itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,693 companies, not a prediction for Dr André HURLET. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €20,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 7.81 (40.0 in 2024), above the usual 1.5. Short-term debt is 10.8% and cash 43.6% of total assets. 11.1% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €236,039
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 7.81, cash €102,969
NBB · annual accounts
lowers risk · Equity €209,941 (88.9% of total assets)
NBB · annual accounts
raises risk · No main activity registered
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
4 days late
2023
on the day
2022
on the day
2021
23 days late
2020
24 days late
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 5 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end06-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

AH
André HURLET
Director
Board & ownership

Recent changes

Amendment of the articles · Legal-form change · Resignations & appointments Director in office: André HURLET (director (not named in the articles)) · Gazette deed
Incorporation published on 10-07-2007 · Gazette deed
All 30 events

Official details

Source: KBO
Status
Active since 29-06-2007Normal situation
Activity
“La société a pour objet l'exercice de la médecine par le ou les associés…” (deed in French)From the articles, 9 activitiesNo NACE code in the KBO yet
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

Turnover
≈ €180,000estimated
Total assets
€236,039▲ 20.6%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on Dr André HURLET

Dr André HURLET files the micro format. That format states no turnover. The gross margin fell from €73,853 in 2008 to €59,821 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr André HURLET

What is the company number of Dr André HURLET?
The company number of Dr André HURLET is 0890.458.218. The VAT number is the same number with BE in front: BE 0890.458.218.
Where is Dr André HURLET based?
The registered office is at Rue du Vieux Bois 11, 4130 Esneux.Company details
What is the legal form of Dr André HURLET?
Dr André HURLET is a private limited company (BV).
When was Dr André HURLET founded?
Dr André HURLET was founded on 29-06-2007.
Is Dr André HURLET still active?
Yes, Dr André HURLET is an active enterprise in the KBO register.
What is the turnover of Dr André HURLET?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €59,821 and 2,667 comparable companies of the same size. It probably lies between €120,000 and €310,000. It is a rough estimate.Financials
Is Dr André HURLET profitable?
In financial year 2025, Dr André HURLET made a profit of €36,734.
Where can I find the annual accounts of Dr André HURLET?
Dr André HURLET filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr André HURLET due?
Dr André HURLET must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.